fluphenazine decanoate

DRUG2 trials

Sponsors

National Institute of Mental Health (NIMH), Tufts Medical Center

Conditions

PsoriasisSchizophrenia

Phase 2

Fluphenazine Decanoate for Psoriasis

TerminatedNCT00356200

Tufts Medical CenterPsoriasis

Start: 2006-07-31End: 2008-09-30Updated: 2010-12-22

Phase 4

CATIE- Schizophrenia Trial

CompletedNCT00014001

National Institute of Mental Health (NIMH)Schizophrenia

Start: 2000-12-31End: 2004-12-31Target: 1600Updated: 2015-06-17

Related Papers

Ensuring generalizability and clinical utility in mental health care applications: Robust artificial intelligence-based treatment predictions in diverse psychosis populations.

2025-11-06

Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial.

2022-08-2820 citations

Prediction of quality of life in schizophrenia using machine learning models on data from Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial

Schizophrenia2022-03-2120 citations

Insomnia, Suicidal Ideation, and Suicide Attempts in the Clinical Antipsychotic Trials of Intervention Effectiveness

The Journal of Clinical Psychiatry2021-03-2329 citations

Course of Psychosis in Schizophrenia With Alcohol Use Disorder

The Journal of Clinical Psychiatry2020-03-165 citations

A case study of SMART attributes: a qualitative assessment of generalizability, retention rate, and trial quality.

2016-05-148 citations

Prognostic Subgroups for Remission, Response, and Treatment Continuation in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Trial

The Journal of Clinical Psychiatry2015-09-1117 citations

Determinants of Patient-Rated and Clinician-Rated Illness Severity in Schizophrenia

The Journal of Clinical Psychiatry2014-12-2324 citations

Motivational Deficits and Cognitive Test Performance in Schizophrenia

JAMA Psychiatry2014-07-30150 citations

Impact of Once- Versus Twice-Daily Perphenazine Dosing on Clinical Outcomes

The Journal of Clinical Psychiatry2014-01-3017 citations

Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.

2010-08-1045 citations